News Briefs

2017 Issue 4
2017 Issue 3
2017 Issue 2
2017 Issue 1
2016 Issue 5
2016 Issue 4
2016 Issue 3
2016 Issue 2
2016 Issue 1
2015 Issue 5
2015 Issue 4
2015 Issue 3
2015 Issue 2
2015 Issue 1
Winter 2013
Maine Message
News Briefs
Will on the Hill: Stepping Up for STEM
Academy in Action
Around the World
A Legacy of Leadership
And the Award Goes to...Pharmacy Educators
Words Worth Spreading
Members Working for You: Weighing the Options
Faculty News
The Last Word
School News Submission Form

News Briefs 

First IOM Pharmacy Fellow Named

AACP and the American College of Clinical Pharmacy, with a generous gift in honor of AACP President J. Lyle Bootman, Ph.D., have pledged $826,000 to the Institute of Medicine (IOM) to create a permanent two-year pharmacy fellowship. Dr. Samuel G. Johnson, clinical pharmacy specialist at Kaiser Permanente Colorado in Denver and clinical instructor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, has been selected as the 2012–2014 Anniversary Fellow. Johnson’s current practice focuses on the clinical applications of personalized medicine for Kaiser patients in the Denver region. “With a major contribution from Research Corporation Technologies and the Frederick Gardner Cottrell Foundation, we are pleased to provide this grant, which will enable early career health scientists in the field of pharmacy to gain valuable experience in shaping policies that improve the nation’s health,” said Bootman, dean of the College of Pharmacy at The University of Arizona. Each fellow will be assigned to an IOM board and is expected to continue his or her academic posts. The IOM provides objective, evidence-based advice to policymakers, health professionals, the private sector and the public. For more information about the fellowship, visit and search Samuel G. Johnson.

Ohio State Tackles Collegiate Prescription Drug Abuse

The Ohio State University College of Pharmacy, in partnership with several state and national agencies and other campus units, offered its first Collegiate Prescription Drug Abuse Prevention Conference in August. The two-day event hosted more than 120 attendees from 28 colleges and universities, nonprofit organizations and government agencies. Prescription drug abuse has been on the rise and, according to the Centers for Disease Control and Prevention, is now the leading cause of accidental death in the United States. College campuses are not immune to this issue, with one in four people aged 18 to 20 reporting having used medications non-medically at least once in their lives, according to the National Survey on Drug Use and Health. Participants formed teams of three to five people, attending group sessions and workshops aimed at creating plans to implement on their campuses. Teams were also able to apply for small grants made possible by the Cardinal Health Foundation and the Ohio Department of Health to help implement these prevention strategies. Resources that resulted from the conference are available at

OU Scientists Studying Protein’s Role in Alzheimer’s Disease

Low-grade inflammation in the brain is believed to play a significant role in the progression of Alzheimer’s disease, releasing toxic substances that can kill neurons and contribute to cognitive decline. But key to that process may be a protein called CAP37 that acts as an inflammatory mediator in the brain, said Dr. H. Anne Pereira, a professor and associate dean for research at The University of Oklahoma College of Pharmacy. The expression of CAP37 has been observed in the brains of individuals dying from Alzheimer’s disease. “We want to know whether CAP37 plays a neuroprotective or neurotoxic role in the brains of patients with Alzheimer’s disease,” said Pereira, whose research is funded by a three-year, $135,000 grant from the Oklahoma Center for the Advancement of Science and Technology. “By identifying the manner in which CAP37 interacts with neurons and other cells in the brain known as microglia, we will better understand the process of neuroinflammation and be able to design potential new drugs for halting or slowing the disease process.”

Students Begin Translational Program at UT Austin

University of Texas at Austin student pharmacists Julieta Scalo and Kelly Daniels are members of the first class working toward a Ph.D. in translational science, a cooperative program involving UT Austin and three other University of Texas System institutions. The program, which is one of about 20 translational science Ph.D. programs in the United States, trains scientists to move health and medical discoveries from the research laboratory to the patient at a faster pace. Daniels will study the prevention and treatment of healthcare-associated infections, such as pneumonia and catheter-related bloodstream infections. Scalo will study oncology and work on a project that investigates the treatment of sleep disturbances in cancer patients. “This program will lead to well-trained individuals who are able to mobilize scientific discoveries and apply them in ways that are helpful to patients,” said Dr. Chris Frei, an associate professor in the College of Pharmacy who is involved in the program.

University of Maryland Report Focuses on Hard-to-Reach Patients

“Integrating Patients’ Voices in Study Design Elements,” a report based on a six-month study led by the University of Maryland School of Pharmacy, encourages medical researchers to include hard-to-reach patients in future studies and clinical trials. “Researchers usually don’t [reach out] to some groups of patients perhaps because it takes more time and effort to include them,” said Dr. C. Daniel Mullins, study leader and a professor in the Department of Pharmaceutical Health Services Research at the school. “But these overlooked people typically have greater health needs.” Mullins received a contract from the Patient-Centered Outcomes Research Institute (PCORI), an independent agency created to help patients, their caregivers and clinicians make better-informed healthcare decisions. His consortium of leaders from community and research groups in Baltimore—including interprofessional faculty members at the university—gathered feedback in dozens of focus groups from caregivers and hard-to-reach patients with different medical conditions. Among the coalition’s suggestions: use a period of “pre-engagement” when recruiting research participants and partners; involve the full spectrum of people who will be affected by the research; and provide a lay summary of findings at an end-of-study celebration.

In Memoriam

Maven J. Myers

Dr. Maven J. Myers, faculty member at the University of the Sciences Philadelphia College of Pharmacy, died on May 6, 2011. He was born in Scranton, Pennsylvania, and later lived in Springfield, Pennsylvania, and Port St. Lucie, Florida. Myers began teaching at the college in 1965 in pharmacy administration and pharmacy law. He moved through the ranks of the professorate, holding posts such as professor of pharmacy administration, chair of the department of pharmacy, associate dean for pharmacy, dean of health sciences and vice president of academic affairs. While he was dean of health sciences, Myers facilitated the curricular issues to implement the general education requirements for all students. He was an advisor to Phi Delta Chi and was engaged with students on many levels. He was chairman of the American Pharmaceutical Association’s Economics and Administrative Sciences Section, served on numerous national editorial boards and was local president of the American College of Apothecaries, in addition to serving as an officer in many other pharmacy associations.

Anthony P. Sorrentino

Dr. Anthony P. Sorrentino passed away on Sept. 24, 2012. He was engaged in various roles with the University of the Sciences Philadelphia College of Pharmacy since he first arrived as a student in 1955. He served as an adjunct faculty member since 1972. Sorrentino joined the university full time in 1996 as the director of experiential resources for the Doctor of Pharmacy program and was appointed as a full-time faculty member in 2004. He retired from the university in 2009 and was awarded the first Anthony Sorrentino Graduation Award for excellence in hospital and health-system pharmacy in spring 2012. Following graduation with his bachelor’s degree in pharmacy in 1959, Sorrentino practiced community pharmacy before joining the Pharmacy Department at the Hospital of the University of Pennsylvania in 1966 as an assistant director. He returned to the University of the Sciences, where he obtained his doctor of pharmacy degree in 1971. He then served as the director of pharmacy for what is now Penn Presbyterian Medical Center. In 1978 he became the assistant director for outpatient pharmacy services and manager of the Jefferson Apothecary.

Joseph V. Swintosky

Dr. Joseph V. Swintosky, dean emeritus of the University of Kentucky (UK) College of Pharmacy, died on Sept. 13, 2012, at the age of 90. He was an accomplished educator and product formulation scientist, who helped lead the college to prominence during his tenure as dean from 1967 to 1987. A native of Kewaunee County, Wisconsin, Swintosky received his bachelor’s degree and Ph.D. in pharmacy from the University of Wisconsin-Madison. In 1967, Swintosky became the fourth dean of the UK College of Pharmacy. The university established the Dr. Joseph V. Swintosky Distinguished Lecture in his honor in 1994. Swintosky also helped found and organize the American Pharmacists Association Academy of Pharmaceutical Sciences (now known as the APhA Academy of Pharmaceutical Research and Science) and became its second president in 1967. Frank D. O’Connell Dr. Frank D. O’Connell, professor emeritus at West Virginia University, passed away on Sept. 4, 2012. He was born in Lynn, Massachusetts, on July 21, 1927, and later resided in Morgantown, West Virginia. A veteran of the U.S. Army, he was stationed in Berlin during the occupation in 1946 and was honorably discharged in 1947. After graduating from the Massachusetts College of Pharmacy with his bachelor’s and master’s degrees, O’Connell was awarded a Ph.D. in pharmacognosy from Purdue University in 1957 and subsequently accepted an assistant professorship at the West Virginia University School of Pharmacy. During his 33 years at WVU, he was promoted to associate and full professor, was appointed associate dean, served as acting dean and was awarded professor emeritus upon his retirement in 1990.

Amy E. Lodolce

Dr. Amy E. Lodolce, adjunct associate professor in the Department of Pharmacy Practice at the University of Illinois at Chicago College of Pharmacy, and assistant director, UIC-COP Drug Information Group, passed away on Aug. 31, 2012, after fighting a recent illness. Lodolce taught at the Chicago State University College of Pharmacy in the literature evaluation and evidence-based medicine course for second-year student pharmacists. Lodolce received a Pharm.D. from UIC in 1998. She completed a pharmacy residency program at Michael Reese Hospital and then joined UIC’s College of Pharmacy as a clinical assistant professor and as a clinical pharmacist and drug information specialist. In 2005, she was promoted to assistant director of drug information. She was also a faculty advisor to Phi Delta Chi, a professional pharmacy fraternity.

Last updated on: 3/13/2013 10:45 AM 

© 2017 American Association of Colleges of Pharmacy
1727 King Street | Alexandria, VA  22314 | (703) 739-2330 | Fax: (703) 836-8982 |